Connor, Clark & Lunn Investment Management (CC&L)’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-326,317
| Closed | -$600K | – | 1593 |
|
|
2024
Q4 | $600K | Sell |
326,317
-110,734
| -25% | -$204K | ﹤0.01% | 1095 |
|
|
2024
Q3 | $1.51M | Buy |
+437,051
| New | +$1.51M | 0.01% | 747 |
|
|
2023
Q1 | – | Sell |
-65,227
| Closed | -$527K | – | 1442 |
|
|
2022
Q4 | $527K | Buy |
65,227
+5,856
| +10% | +$47.3K | ﹤0.01% | 847 |
|
|
2022
Q3 | $330K | Buy |
59,371
+33,441
| +129% | +$186K | ﹤0.01% | 900 |
|
|
2022
Q2 | $135K | Buy |
+25,930
| New | +$135K | ﹤0.01% | 968 |
|
|
2022
Q1 | – | Sell |
-21,894
| Closed | -$326K | – | 1207 |
|
|
2021
Q4 | $326K | Sell |
21,894
-16,513
| -43% | -$246K | ﹤0.01% | 879 |
|
|
2021
Q3 | $726K | Buy |
38,407
+14,687
| +62% | +$278K | ﹤0.01% | 701 |
|
|
2021
Q2 | $441K | Buy |
23,720
+9,258
| +64% | +$172K | ﹤0.01% | 809 |
|
|
2021
Q1 | $329K | Buy |
14,462
+3,342
| +30% | +$76K | ﹤0.01% | 851 |
|
|
2020
Q4 | $241K | Buy |
+11,120
| New | +$241K | ﹤0.01% | 813 |
|